Document is current
Any future updates will be listed below
-
Authors
Tashiro, Syoichi https://orcid.org/0000-0002-1430-0552
Tsuji, Osahiko https://orcid.org/0000-0002-4584-1757
Shinozaki, Munehisa https://orcid.org/0000-0002-1116-2713
Shibata, Takahiro
Yoshida, Takashi
Tomioka, Yohei
Unai, Kei
Kondo, Takahiro
Itakura, Go
Kobayashi, Yoshiomi
Yasuda, Akimasa
Nori, Satoshi
Fujiyoshi, Kanehiro
Nagoshi, Narihito
Kawakami, Michiyuki
Uemura, Osamu https://orcid.org/0000-0002-2553-8144
Yamada, Shin
Tsuji, Tetsuya
Okano, Hideyuki
Nakamura, Masaya
-
Funding
Funding for this research was provided by:
School of Medicine, Kyorin University
Japan Agency for Medical Research and Development (JP20bm0204001)
Japan Agency for Medical Research and Development (JP19bm0204001)
Japan Agency for Medical Research and Development (JP18bk0104017)
Japan Agency for Medical Research and Development (JP20bm0204001)
Japan Agency for Medical Research and Development (JP19bm0204001)
Japan Agency for Medical Research and Development (JP18bk0104017)
- License Information
-
More Information
Article History
Received: 19 February 2021
Accepted: 21 October 2021
First Online: 25 November 2021
Competing interests
: M.N. declared a consultancy role with KâPharma Inc. and research funding from RMic and Hisamitsu. H.O. declared a leadership position at Keio University School of Medicine and is a compensated scientific consultant for San Bio Co. Ltd. and K Pharma Inc. The remaining authors declare no competing interests.
